Revolution In Heart Failure Restore Medical has developed the first and only transcatheter Pulmonary Artery Banding (PAB) system for the treatment of HFrEF patients ContraBand™ is an innovative and reversible therapy for the treatment of left ventricle (LV) failure. The catheter-delivered implant is designed to leverage the right ventricle (RV) to provide su
Hiring? Add a featured job
Open roles at Restore Medical
Role and seniority are inferred from job titles and departments. Posting dates come from employers where available; “First seen” means first discovered by IsraelVC. Undated roles sort last.
We haven’t connected this company’s job listings yet. Use the employer’s careers site below for current openings.
Current vacancy count is not yet verified. Applications are handled by the employer.
Reported funding history (1 entries)
Dates refer to published reports. Entries can describe extensions or cumulative funding, so amounts should not be added together.
- 2025-07-07 · $23.0M · Series B
Reported financing
